The Royal Marsden NHS Foundation Trust, 203 Fulham Road, London, SW3 6JJ, UK.
Department of Nursing, King's College London, Waterloo, London, UK.
Support Care Cancer. 2020 Oct;28(10):4881-4889. doi: 10.1007/s00520-020-05309-z. Epub 2020 Jan 29.
Long-term changes in gastrointestinal function impacting quality of life after treatment for cancer are common. Peer reviewed guidance to investigate and manage GI dysfunction following cancer treatment has been published. This study reviewed gastrointestinal symptoms of women previously treated for gynaecological cancer and considered whether suggested algorithms could be amended to optimise management for this cohort.
Demographic and clinical data recorded for patients attending a specialist consequences of cancer treatment gastroenterology service prospectively are reported using median and range. The Wilcoxon signed rank test analysed changes in symptoms between initial assessment to discharge from the service.
Between April 2013 and March 2016, 220 women, with a median age of 57 years (range 24-83 years), treated for gynaecological cancer (cervical (50%)), endometrial (28%), ovarian (15%), vaginal or vulval (7%) attended. Twelve gastrointestinal symptoms were statistically significantly reduced by time of discharge from the specialist gastroenterology clinic including bowel frequency ≥ 4/day (88%), type 6 or 7 stool consistency (36%), urgency (31%) and incontinence (21%). General quality of life improved from a median score of 4 at first assessment to a median of 6 at discharge (p < 0.001). A median of four (range, 1-9) diagnoses were made.
Women with gastrointestinal symptoms after cancer treatment benefit from a systematic management approach. After excluding disease recurrence, a proposed investigational algorithm and the oncology team includes FBC, U&Es, LFTs, thyroid function test, vitamin B, vitamin D, a hydrogen methane breath test and a SeHCAT scan. If rectal bleeding is present, iron studies, flexible sigmoidoscopy or colonoscopy should be performed. Patients with normal investigations or symptoms not responding to treatment require gastroenterology input.
癌症治疗后影响生活质量的胃肠道功能长期变化较为常见。已发布经同行评审的指导意见,以调查和管理癌症治疗后的胃肠道功能障碍。本研究回顾了先前接受妇科癌症治疗的女性的胃肠道症状,并考虑是否可以修改建议的算法以优化该队列的管理。
使用中位数和范围报告前瞻性记录的参加专门的癌症治疗后胃肠病学服务的患者的人口统计学和临床数据。采用 Wilcoxon 符号秩检验分析从服务初始评估到出院期间症状的变化。
2013 年 4 月至 2016 年 3 月,220 名年龄中位数为 57 岁(范围 24-83 岁)的女性因妇科癌症(宫颈癌(50%)、子宫内膜癌(28%)、卵巢癌(15%)、阴道或外阴癌(7%))接受治疗。12 种胃肠道症状在从专门的胃肠病学诊所出院时统计学上显著减少,包括每天排便≥4 次(88%)、大便类型 6 或 7(36%)、急迫感(31%)和失禁(21%)。总体生活质量从首次评估时的中位数 4 分提高到出院时的中位数 6 分(p<0.001)。中位数诊断 4 种(范围,1-9)疾病。
癌症治疗后有胃肠道症状的女性受益于系统的管理方法。在排除疾病复发后,拟议的检查算法和肿瘤团队包括全血细胞计数、血尿素氮、电解质、肝肾功能检查、甲状腺功能检查、维生素 B、维生素 D、氢甲烷呼气试验和 SeHCAT 扫描。如果存在直肠出血,应进行铁研究、软性乙状结肠镜检查或结肠镜检查。如果检查正常或症状对治疗无反应,需要进行胃肠病学检查。